WS Investor
05 Oct 2026, 14:11
GlobalFoundries Stock Falls 4.2% After BNP Paribas Exane Downgrade
GlobalFoundries shares fell 4.2% to $48.07 after BNP Paribas Exane downgraded the stock to Neutral from Outperform.
Analyst Karl Ackerman maintained a $51 price target, leaving relatively limited upside from the current share price.
Probable reasons behind the downgrade include a more balanced risk-reward profile after recent performance, ongoing softness in parts of the broader semiconductor cycle, and uncertainty around the pace of recovery in end markets such as automotive, industrial and communications.
GlobalFoundries remains strategically positioned in specialty and mature-node semiconductor manufacturing, where demand is generally less tied to leading-edge AI chips than peers focused on advanced-node production. That can provide some stability, but it can also limit participation in the strongest areas of semiconductor growth.
The stock’s decline suggests investors are focusing on the move to a more cautious rating and the modest gap between the current share price and BNP Paribas Exane’s $51 target.
GlobalFoundries shares fell 4.2% to $48.07 after BNP Paribas Exane downgraded the stock to Neutral from Outperform.
Analyst Karl Ackerman maintained a $51 price target, leaving relatively limited upside from the current share price.
Probable reasons behind the downgrade include a more balanced risk-reward profile after recent performance, ongoing softness in parts of the broader semiconductor cycle, and uncertainty around the pace of recovery in end markets such as automotive, industrial and communications.
GlobalFoundries remains strategically positioned in specialty and mature-node semiconductor manufacturing, where demand is generally less tied to leading-edge AI chips than peers focused on advanced-node production. That can provide some stability, but it can also limit participation in the strongest areas of semiconductor growth.
The stock’s decline suggests investors are focusing on the move to a more cautious rating and the modest gap between the current share price and BNP Paribas Exane’s $51 target.
